ID   NALM-25
AC   CVCL_5664
SY   NALM25
DR   JCRB; JCRB1828
DR   Wikidata; Q54907407
RX   PubMed=1667895;
RX   PubMed=9680106;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=1667895; PubMed=10071072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1828
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D5S818: 10
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 14
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX01 ! B262
OI   CVCL_3888 ! NALM-24
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
RX   PubMed=1667895;
RA   Matsuo Y., Ariyasu T., Adachi T., Tsubota T., Minowada J.;
RT   "Two t(9;22) leukemia cell lines (NALM-24 and NALM-25) with
RT   bi-phenotypic characteristics and an EBV-positive B-cell non-leukemia
RT   cell line (B262) established from a patient with acute lymphoblastic
RT   leukemia.";
RL   Hum. Cell 4:339-342(1991).
//
RX   PubMed=9680106; DOI=10.1016/S0145-2126(98)00050-2;
RA   Matsuo Y., Drexler H.G.;
RT   "Establishment and characterization of human B cell precursor-leukemia
RT   cell lines.";
RL   Leuk. Res. 22:567-579(1998).
//
RX   PubMed=10071072; DOI=10.1016/S0145-2126(98)00171-4;
RA   Drexler H.G., MacLeod R.A.F., Uphoff C.C.;
RT   "Leukemia cell lines: in vitro models for the study of Philadelphia
RT   chromosome-positive leukemia.";
RL   Leuk. Res. 23:207-215(1999).
//